Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus

Background and aims: Bromocriptine is a dopaminergic (D2) agonist that has shown hypoglycemic and normotensive activity in preclinical and clinical studies. The main objective of this study was to investigate the effect of bromocriptine plus metformin on glycaemia and blood pressure in patients with...

Full description

Bibliographic Details
Main Authors: Briones-Aranda Alfredo, Ramírez-Carballo Javier, Gómez Bernardo Alfredo Romero, Villa Victor Manuel Vega, Pérez Manuela Castellanos, Parra Esmeralda Garcia, Santeliz-Montero Hugo Roberto
Format: Article
Language:English
Published: Sciendo 2018-03-01
Series:Romanian Journal of Diabetes Nutrition and Metabolic Diseases
Subjects:
Online Access:https://doi.org/10.2478/rjdnmd-2018-0006